AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sirtori, C. R.
Right arrow Articles by Kritchevsky, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirtori, C. R.
Right arrow Articles by Kritchevsky, D.
Agricola
Right arrow Articles by Sirtori, C. R.
Right arrow Articles by Kritchevsky, D.

American Journal of Clinical Nutrition, Vol 32, 1645-1658, Copyright © 1979 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia

CR Sirtori, E Gatti, O Mantero, F Conti, E Agradi, E Tremoli, M Sirtori, L Fraterrigo, L Tavazzi and D Kritchevsky

The efficacy of the total substitution of animal proteins with a textured soybean protein in hypercholesterolemic individuals was assayed in 42 in-patients and 18 out-patients. The in-patients studied followed one of three different crossover protocols: in protocol A, the soybean diet was compared with a standard low lipid diet; protocol B compared two soybean diets, one with added cholesterol, one without; and protocol C compared a soybean diet containing a high P/S fatty acid ratio to one with a low P/S ratio. In all three protocols, the soybean regimen provided valid and reproducible hypocholesterolemic effects that were not modified by the addition of cholesterol. P/S variations appeared, however, to modify the final effect: soybean definitely had a decreased effectiveness with a low P/S (0.1) regimen. The overall plasma cholesterol changes in the 42 in-patients after 3 weeks on the different soybean diet protocols was -20%. Patients with type IIA and IIB hypercholesterolemia provided almost equivalent results, whereas patients with mixed phenotypes (IIB-III) appeared somewhat more sensitive to the dietary effect. Cholesterol decreased mostly in the low density lipoprotein fraction, but some very low density lipoprotein changes were also noted upon variation of the P/S ratio. The out- patients studied provided less satisfactory results. possibly due to the difficulty of adequately complying with the diet. These studies indicate that treatment with the soybean diet is an effective regimen for inducing a significant cholesterol reduction in type II patients refractory to standard low lipid regimens.


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
N. R Matthan, S. M Jalbert, L. M Ausman, J. T Kuvin, R. H Karas, and A. H Lichtenstein
Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 960 - 966.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, M. Winston, and for the AHA Nutrition Committee
Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee.
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1689 - 1692.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. J. Jenkins, C. W. Kendall, D. A Faulkner, T. Nguyen, T. Kemp, A. Marchie, J. M. Wong, R. de Souza, A. Emam, E. Vidgen, et al.
Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia
Am. J. Clinical Nutrition, March 1, 2006; 83(3): 582 - 591.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, M. Winston, and for the American Heart Association Nutrition Commi
Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee
Circulation, February 21, 2006; 113(7): 1034 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. J. Jenkins, C. W. Kendall, A. Marchie, D. A Faulkner, J. M. Wong, R. de Souza, A. Emam, T. L Parker, E. Vidgen, E. A Trautwein, et al.
Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 380 - 387.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. R. Crouse III, T. Morgan, J. G. Terry, J. Ellis, M. Vitolins, and G. L. Burke
A Randomized Trial Comparing the Effect of Casein With That of Soy Protein Containing Varying Amounts of Isoflavones on Plasma Concentrations of Lipids and Lipoproteins
Arch Intern Med, September 27, 1999; 159(17): 2070 - 2076.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M. Segasothy and P.A. Phillips
Vegetarian diet: panacea for modern lifestyle diseases?
QJM, September 1, 1999; 92(9): 531 - 544.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. W. Anderson, B. M. Johnstone, and M. E. Cook-Newell
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
N. Engl. J. Med., August 3, 1995; 333(5): 276 - 282.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by The American Society for Nutrition